NCT03651037 (THRIVORS+BH) is a NA clinical trial of Thrivors+BH in Breast Cancer, sponsored by Thrivors Inc.

Who is sponsoring NCT03651037?

NCT03651037 is sponsored by Thrivors Inc.

What drugs are being tested in NCT03651037?

Interventions in NCT03651037: Thrivors+BH.

What condition does NCT03651037 study?

NCT03651037 studies Breast Cancer, Physical Activity, Bone Health.

Is NCT03651037 still recruiting?

NCT03651037 is currently completed. Last updated 1 September 2020.

Last reviewed 2020-09-01 · How we verify

NCT03651037: THRIVORS+BH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Activity Platform to Improve Bone Health in Cancer Survivors

Completed NA Last updated 1 September 2020

What this trial tests

NA trial testing Thrivors+BH in Breast Cancer in 134 participants. Completed in 1 March 2020.

Timeline

21 January 2019

Primary endpoint
1 March 2020

1 March 2020

Quick facts

Lead sponsor	Thrivors Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	134
Start date	21 January 2019
Primary completion	1 March 2020
Estimated completion	1 March 2020
Sites	1 location across United States

Drugs / interventions tested

Thrivors+BH

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Physical Activity — all drugs for Physical Activity →
Bone Health — all drugs for Bone Health →

Sponsor

Thrivors Inc

Who can join

Adults 40 to 70, female only, with Breast Cancer or Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cancer treatment-induced bone loss and the subsequent risk of fractures in both men and women impacts not just survivors' quality of life, but is also a significant burden on national health care. Clinical studies have reported that moderate-intensity resistance exercises prevent a decline in bone health in female cancer survivors, and that strength training may reduce complications associated with cancer such as fatigue, muscle wasting, and bone loss. Unfortunately, only a small percentage of women who have had cancer, engage in and adhere to a strength training exercise routine. The investigators have developed an internet-based application, Thrivors, that guides cancer survivors through exercise routines with light-to-moderate strength training in the home setting, and connects them to survivorship resources. In this Phase I proposal, the investigators will develop and deploy an enhanced version, Thrivors+BH, that disseminates resistance training exercises specifically impacting bone health (BH), integrated with video-based interactive feedback and tracking of adherence to exercise routines. The goal is to validate Thrivors+BH as a novel tool to bridge the gaps between cancer survivorship, physical activity, value-based care and health care organizations (providers and payers), to positively impact bone health in breast cancer survivors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03651037 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thrivors Inc
Last refreshed: 1 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03651037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing